We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib.
- Authors
Gambacorti-Passerini, Carlo; Antolini, Laura; Mahon, François-Xavier; Guilhot, Francois; Deininger, Michael; Fava, Carmen; Nagler, Arnon; Della Casa, Chiara Maria; Morra, Enrica; Abruzzese, Elisabetta; D'Emilio, Anna; Stagno, Fabio; le Coutre, Philipp; Hurtado-Monroy, Rafael; Santini, Valeria; Martino, Bruno; Pane, Fabrizio; Piccin, Andrea; Giraldo, Pilar; Assouline, Sarit; Durosinmi, Muheez A; Leeksma, Onno; Pogliani, Enrico Maria; Puttini, Miriam; Jang, Eunjung; Reiffers, Josy; Piazza, Rocco; Valsecchi, Maria Grazia; Kim, Dong-Wook
- Abstract
Imatinib slows development of chronic myeloid leukemia (CML). However, available information on morbidity and mortality is largely based on sponsored trials, whereas independent long-term field studies are lacking.
- Publication
Journal of the National Cancer Institute, 2011, Vol 103, Issue 7, p553
- ISSN
1460-2105
- Publication type
Journal Article
- DOI
10.1093/jnci/djr060